Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: Effect on in vivo mammary tumor growth and angiogenesis

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3450-3457

  Hajitou, Amin ^a,b   Sounni, Nor Eddine ^a   Devy, Laetitia ^a   Grignet Debrus, Christine ^a   Lewalle, Jean Marc ^a   Li, Hong ^c   Deroanne, Christophe F ^a   Lu, He ^c   Colige, Alain ^a   Frankenne, Francis ^a   Yeh, Patrice ^b   Perricaudet, Michel ^b   Chang, Yawen ^d   Soria, Claudine ^c   Calberg Bacq, Claire Michelle ^a   Foidart, Jean Michel ^a   Noël, Agnès ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CNRS   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d Aventis Gencell   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOGENESIS; CANCER GROWTH; CONTROLLED STUDY; ENZYME REGULATION; GENE TRANSFER; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ADENOVIRIDAE; ANGIOSTATINS; ANIMALS; CELL DIVISION; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTORS; GENE TRANSFER TECHNIQUES; LYMPHOKINES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; RATS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035870250     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Angiogenesis in cancer, vascular, rheumatoid, and other disease
2. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
3. Mechanisms of angiogenesis and arteriogenesis
4. Emerging roles for proteinases in cancer
5. Matrix metalloproteinases
6. Tissue inhibitors of matrix metalloproteinases
7. Tissue inhibitors of metalloproteinases: Structure, regulation, and biological functions
8. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2
9. Engineering of selective TIMPs
10. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
11. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
12. Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis
13. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
14. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
15. Inhibition of stromal matrix metalloproteases: Effects on breast-tumor promotion by fibroblasts
16. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity
17. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
18. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
19. High levels of TIMP-2 correlate with adverse prognosis in breast cancer
20. The role of metalloproteinases and their inhibitors in hematological disorders
21. Activation mechanisms of matrix metalloproteinases
22. Membrane type I matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines
23. Fibroblast growth factor 3 is tumorigenic for mouse mammary cells orthotopically implanted in nude mice
24. FGF-3 and FGF-4 elicit district oncogenic properties in mouse mammary myoepithelial cells
25. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression
26. A simple, rapid, and sensitive DNA assay procedure
27. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor
28. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
29. Widespread long-term gene transfer to mouse skeletal muscles and heart
30. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
31. Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein
32. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro
33. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein
34. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism
35. Matrix metalloproteinase inhibition: A review of antitumor activity
36. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
37. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation
38. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro
39. Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products
40. Proteolytic control of growth factor availability
41. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
42. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation